AiM  Vol.8 No.7 , July 2018
Linear Thanatin Is an Effective Antimicrobial Peptide against Colistin-Resistant Escherichia coli in Vitro
Abstract: Colistin has been regarded as the last line antibiotic for treatment of infections caused by multidrug resistant gram-negative bacteria. Therefore, the increasing emergence of colistin resistance among gram-negative bacteria represents a serious problem. The objective of this study was to characterize the effectiveness of the chemically synthesized thanatin in linear form against colistin-resistant E. coli isolated from a pig farm in China. Agar diffusion assay and broth microdilution test were employed to analyze the susceptibility of colistin-sensitive E. coli (ATCC25922) and colistin-resistant E. coli (SHP45) to linear thanatin (L-thanatin). Combinatory effect of linear thanatin and colistin against E. coli was also determined by fractional inhibition concentration index (FICI) analysis. The results showed that L-thanatin at a concentration of 1 mg/ml produced larger inhibition zone on agar against ATCC25922 than SHP45. In the quantitative microdilution test, L-thanatin had the same MIC of 3.2 μg/ml for ATCC25922 and SHP45. Based on the FICI analysis, additive effect was obtained with 1.56 μg/ml of L-thanatin and 0.125 μg/ml of colistin for ATCC25922; but with 1.56 μg/ml of L-thanatin and 0.25 μg/ml of colistin or with 2 μg/ml of colistin and 0.39 μg/ml of L-thanatin for SHP45. These data proved that L-thanatin is an effective antimicrobial peptide against colistin-resistant E. coli.
Cite this paper: Zhou, Q. , Fan, H. , Lu, P. , Zhou, Y. , Li, W. and Liu, J. (2018) Linear Thanatin Is an Effective Antimicrobial Peptide against Colistin-Resistant Escherichia coli in Vitro. Advances in Microbiology, 8, 589-599. doi: 10.4236/aim.2018.87039.

[1]   Thabit, A.K., Crandon, J.L. and Nicolau, D.P. (2015) Antimicrobial Resistance: Impact on Clinical and Economic Outcomes and the Need for New Antimicrobials. Expert Opinion on Pharmacotherapy, 16, 159-177.

[2]   Moxon, C.A. and Paulus, S. (2016) Beta-Lactamases in Enterobacteriaceae Infections in Children. Journal of Infection, 72, S41-S49.

[3]   Ainsworth, G.C., Brown, A.M. and Brownlee, G. (1947) Aerosporin, an Antibiotic Produced by Bacillus aerosporus Greer. Nature, 159, 263.

[4]   Schoenbach, E.B. and Bryer, M.J. (1948) The Clinical Use of Polymyxin. Bulletin of Johns Hopkins Hospital, 82, 637-639.

[5]   Brown, P. and Dawson, M.J. (2017) Development of New Polymyxin Derivatives for Multi-Drug Resistant Gram-Negative Infections. The Journal of Antibiotics (Tokyo), 70, 386-394.

[6]   Rhouma, M., Beaudry, F., Thériault, W. and Letellier, A. (2016) Colistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health Perspectives. Frontiers in Microbiology, 7, 1789.

[7]   Harada, K., Asai, T., Kojima, A., Oda, C., Ishihara, K. and Takahashi, T. (2005) Antimicrobial Susceptibility of Pathogenic Escherichia coli Isolated from Sickcattle and Pigs in Japan. Journal of Veterinary Medical Science, 67, 999-1003.

[8]   Enne, V.I., Cassar, C., Sprigings, K., Woodward, M.J. and Bennett, P.M. (2008) A High Prevalence of Antimicrobial Resistant Escherichia coli Isolated from Pigs and a Low Prevalence of Antimicrobial Resistant E. coli from Cattle and Sheep in Great Britain at Slaughter. FEMS Microbiology Letters, 278, 193-199.

[9]   Lu, L., Dai, L., Wang, Y., Wu, C., Chen, X., Li, L., Qi, Y., Xia, L. and Shen, J. (2010) Characterization of Antimicrobial Resistance and Integrons among Escherichia coli Isolated from Animal Farms in Eastern China. Acta Tropica, 113, 20-25.

[10]   Olaitan, A.O., Morand, S. and Rolain, J.M. (2014) Mechanisms of Polymyxin Resistance: Acquired and Intrinsic Resistance in Bacteria. Frontiers in Microbiology, 5, 643.

[11]   Liu, Y.Y., Wang, Y., Walsh, T.R., Yi, L.X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., Yu, L.F., Gu, D., Ren, H., Chen, X., Lv, L., He, D., Zhou, H., Liang, Z., Liu, J.H. and Shen, J. (2016) Emergence of Plasmid-Mediated Colistin Resistance Mechanism MCR-1 in Animals and Human Beings in China: A Microbiological and Molecular Biological Study. The Lancet Infectious Diseases, 16, 161-168.

[12]   Olaitan, A.O., Thongmalayvong, B., Akkhavong, K., Somphavong, S., Paboriboune, P., Khounsy, S., Morand, S. and Rolain, J.M. (2015) Clonal Transmission of a Colistin-Resistant Escherichia coli from a Domesticated Pig to a Human in Laos. Journal of Antimicrobial Chemotherapy, 70, 3402-3404.

[13]   Olaitan, A.O., Chabou, S., Okdah, L., Morand, S. and Rolain, J.M. (2016) Dissemination of the MCR-1 Colistin Resistance Gene. The Lancet Infectious Diseases, 16, 147.

[14]   Fehlbaum, P., Bulet, P., Chemysh, S., Briand, J.P., Rousse, J.P., Letellier, L., et al. (1996) Structure Activity Analysis of Thanatin, a 21-Residue Inducible Insect Defense Peptide with Sequence Homology to Frog Skin Antimicrobial Peptides. Proceedings of the National Academy of Sciences, 93, 1221-1225.

[15]   Mandard, N., Sodano, P., Labbe, H., Bonmatin, J.M., Bulet, P., Hetru, C., Ptak, M. and Vovelle, F. (1998) Solution Structure of Thanatin, a Potent Bactericidal and Fungicidal Insect Peptide, Determined from Proton Two-Dimensional Nuclear Magnetic Resonance Data. European Journal of Biochemistry, 256, 404-410.

[16]   Pagès, J.M., Dimarcq, J.L., Quenin, S. and Hetru, C. (2003) Thanatin Activity on Multidrug Resistant Clinical Isolates of Enterobacter aerogenes and Klebsiella pneumoniae. International Journal of Antimicrobial Agents, 22, 265-269.

[17]   Wu, G., Fan, X., Li, L., Wang, H., Ding, J., Hongbin, W., Zhao, R., Gou, L., Shen, Z. and Xi, T. (2010) Interaction of Antimicrobial Peptide s-Thanatin with Lipopolysaccharide in Vitro and in an Experimental Mouse Model of Septic Shock Caused by a Multidrug-Resistant Clinical Isolate of Escherichia coli. International Journal of Antimicrobial Agents, 35, 250-254.

[18]   Wu, G., Li, X., Fan, X., Wu, H., Wang, S., Shen, Z. and Xi, T. (2011) The Activity of Antimicrobial Peptide S-Thanatin Is Independent on Multidrug-Resistant Spectrum of Bacteria. Peptides, 32, 1139-1145.

[19]   Edwards, I.A., Elliott, A.G., Kavanagh, A.M., Zuegg, J., Blaskovich, M.A. and Cooper, M.A. (2016) Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of β-Hairpin Peptides. ACS Infectious Diseases, 2, 442-450.

[20]   Ma, B., Niu, C., Zhou, Y., Xue, X., Meng, J., Luo, X. and Hou, Z. (2016) The Disulfide Bond of the Peptide Thanatin Is Dispensible for Its Antimicrobial Activity in Vivo and in Vitro. Antimicrobial Agents Chemotherapy, 60, 4283-4289.

[21]   Boulanger, N., Munks, R.J., Hamilton, J.V., Vovelle, F., Brun, R., Lehane, M.J. and Bulet, P. (2002) Epithelial Innate Immunity. A Novel Antimicrobial Peptide with Antiparasitic Activity in the Blood-Sucking Insect Stomoxys calcitrans. Journal of Biological Chemistry, 277, 49921-49926.

[22]   Del Valle, P., Garcia-Armesto, M.R., De Arriaga, D., Alez-Donquiles, C.G., Rodriguez-Fernandez, P. and Rua, J. (2016) Antimicrobial Activity of Kaempferol and Resveratrol in Binary Combinations with Parabens or Propyl Gallate against Enterococcus faecalis. Food Control, 61, 213-220.

[23]   Lee, Y.S., Kang, O.H., Choi, J.G., Oh, Y.C., Chae, H.S., Kim, J.H., Park, H., Sohn, D.H., Wang, Z.T. and Kwon, D.Y. (2008) Synergistic Effects of the Combination of Galangin with Gentamicin against Methicillin-Resistant Staphylococcus aureus. The Journal of Microbiology, 46, 283-288.

[24]   Blair, J.M., Webber, M.A., Baylay, A.J., Ogbolu, D.O. and Piddock, L.J. (2015) Molecular Mechanisms of Antibiotic Resistance. Nature Reviews Microbiology, 13, 42-51.

[25]   Alonso, C.A., Zarazaga, M., Ben Sallem, R., Jouini, A., Ben Slama, K. and Torres, C. (2017) Antibiotic Resistance in Escherichia coli in Husbandry Animals: The African Perspective. Letters in Applied Microbiology, 64, 318-334.

[26]   Zavascki, A.P., Goldani, L.Z., Li, J. and Nation, R.L. (2007) Polymyxin B for the Treatment of Multidrug-Resistant Pathogens: A Critical Review. Journal of Antimicrobial Chemotherapy, 60, 1206-1215.

[27]   Bollenbach, T. (2015) Antimicrobial Interactions: Mechanisms and Implications for Drug Discovery and Resistance Evolution. Current Opinion in Microbiology, 27, 1-9.

[28]   Mohammadi, M., Khayat, H., Sayehmiri, K., Soroush, S., Sayehmiri, F., Delfani, S., Bogdanovic, L. and Taherikalani, M. (2017) Synergistic Effect of Colistin and Rifampin against Multidrug Resistant Acinetobacter baumannii: A Systematic Review and Meta-Analysis. The Open Microbiology Journal, 11, 63-71.

[29]   Lenhard, J.R., Nation, R.L. and Tsuji, B.T. (2016) Synergistic Combinations of Polymyxins. International Journal of Antimicrobial Agents, 48, 607-613.

[30]   Velkov, T., Thompson, P.E., Nation, R.L. and Li, J. (2010) Structure-Activity Relationships of Polymyxin Antibiotics. Journal of Medicinal Chemistry, 53, 1898-1916.